Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 771 results found. Search for [ Bharat Biotech COVID-19 vaccine ]

Results 1 to 21 of 771
BusinessToday.In
New Delhi, June 14, 2021
Several private hospitals across the country have said they have no clarity on procuring Covid-19 vaccines under the new policy announced by Prime Minister Narendra Modi and that it has led to the vaccination being put on hold at their centres. The hospitals also flagged the service charge for vaccination being capped at Rs 150, stating it may not be feasible for them to organise sessions outside their own centres at the given prices. They claimed that they had approached the vaccine manufacturers Bharat Biotech and Serum Institute of India (SII) and also state governments, but to no avail. The Centre on June 8 capped the prices of the Covid vaccines administered by private hospitals at ?780 for Covishield, ?1,410 for Covaxin, and ?1,145 for Sputnik V. Watch the video for more.Also Read: Novavax study finds its COVID-19 vaccine 90% effective against virus


PTI
June 13, 2021
The hospitals have sought a proper mechanism and a single-window system to be put in place for procurement of vaccine doses


PTI
June 12, 2021
NITI Aayog member (Health) V K Paul said each country has its own regulatory system which India respects and hoped that the manufacturer will be able to comply with it by doing whatever requires to be done


BusinessToday.In
June 11, 2021
Bharat Biotech's US partner Ocugen said it would no longer seek emergency approval for Covaxin, and would rather file for full approval of the anti-COVID shot


BusinessToday.In
June 9, 2021
The Hyderabad-based company said it will apply for full licence for Covaxin after the release of phase-III data.


BusinessToday.In
June 9, 2021
A 64-member team of the paramilitary force will protect the registered office and plant of the pharma company located at Genome Valley in the Shameerpet area of Hyderabad


BusinessToday.In
June 8, 2021
Around 30 per cent of the advance for procurement of both vaccines has been released to Serum Institute of India and Bharat Biotech, the health ministry said


PTI
June 8, 2021
Bharat Biotech on June 3 said it has agreed to expand the agreement with Ocugen Inc to commercialise the jab in Canada also


Reuters
June 8, 2021
Prime Minister Narendra Modi said in his Monday's address to the nation that the federal government would bear the cost of vaccinating all adults from June 21


BusinessToday.In
June 7, 2021
Saying experts have raised concerns on COVID-19 affecting children, Modi said two vaccines are undergoing trials in the country for use in children.


BusinessToday.In
June 7, 2021
DGCI's approval for Covaxin trials on children was followed by recommendation by the Subject Expert Committee; AIIMS Delhi is not the only hospital to begin Covaxin trials for children


BusinessToday.In
June 7, 2021
The Delhi Disaster Management Authority has also asked health and revenue departments and district magistrates to ensure complete compliance with the order


PTI
June 5, 2021
On February 26, Bharat Biotech Ltd had said it signed an agreement with the Brazilian government for the supply of 20 million doses of Covaxin during the second and third quarters of 2021


Reuters
June 4, 2021
India has been inoculating people with the AstraZeneca vaccine produced locally by the Serum Institute of India (SII) and Covaxin made by local firm Bharat Biotech


BusinessToday.In
June 3, 2021
The self-test kit can be bought at drug stores and chemist shops in 2-3 days. Individuals can also order it online through e-commerce giant Flipkart


PTI
June 3, 2021
Relaxation of restrictions as per the situation in different areas is only under consideration and no decision has been taken, a statement from the Chief Minister's Office (CMO) said


Reuters
June 3, 2021
So far, only about 4.7% of the 950 million adult population have been given two vaccine doses as the world's second-most populous country reels from a devastating second wave of infections


BusinessToday.In
June 3, 2021
Once the company gets permission, it will have to conduct clinical trials and if successful, the Serum Institute will become the seventh company to manufacture Sputnik V


BusinessToday.In
June 3, 2021
The Union Health Ministry will make an advance payment of Rs 1,500 crore to Hyderabad-based drugmaker Biological-E for what will be the second made-in-India vaccine following Bharat Biotech's Covaxin


BusinessToday.In
June 3, 2021
Mumbai has a total of 342 active COVID-19 vaccination centres, of which 243 are managed by the BMC and 20 by the state government


PAGES 1 OF 39  12345